top of page

Volumina Medical secures USD 21 Million Funding to continue its Clinical Program after having obtained promising First in Human Data

Epalinges, Switzerland, March 25, 2024 - Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery, announces the successful closing of their Series A round by existing and new investors. It will enable Volumina Medical to confidently advance its clinical program with its lead product AdipearlTM, and ultimately achieve market approval in key international markets.

Press release Series A - Volumina Medical
Download PDF • 129KB


bottom of page